Pharmaceutical - Journal of Pharmaceutics & Pharmacology https://www.avensonline.org/ Preparation and Evaluation of Glaucocalyxin A Sustained- Release Pellets Based on Phospholipid Complex System with Enhanced Bioavailability https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0030.html 07 August 2020 Miao YF and Sun JQ Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0031.html 10 September 2020 Smieszek SP, Przychodzen BP, and Polymeropoulos MH Innovative Approaches to Enhance Dissolution Rate of a Hydrophobic Drug Glimepiride https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0031.html 28 October 2020 Ismail Shehada MB, Usman S, Akram M and Usman A The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0032.html 21 September 2020 Aranda-Abreu GE, Hernández-Aguilar ME, Herrera-Covarrubias D and Rojas-Durán F Amantadine for the Treatment of SARS-Cov-2: Case Report https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0033.html 21 September 2020 Aranda-Abreu GE, Aranda-Martínez JD and Araújo R Adamantanes for the Prevention of COVID-19: A Review of Case Reports https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0034.html 29 September 2020 Cortes Borra A Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0035.html 16 September 2020 Butterworth Roger F Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0037.html 12 October 2020 Butterworth Roger F Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0038.html 24 November 2020 Brenner SR and Butterworth RF Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 24 November 2020 Roger F Butterworth